Healthcare - Biotechnology - NASDAQ - US
$ 1.93
2.12 %
$ 2.76 M
Market Cap
0.05
P/E
Price Target
Average
521.76%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
19.23%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Avenue Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ATXI of $12 , with forecasts ranging from a low of $12 to a high of $12 .
ATXI Lowest Price Target
Wall Street Target
12 USD
521.76%
ATXI Average Price Target
Wall Street Target
12 USD
521.76%
ATXI Highest Price Target
Wall Street Target
12 USD
521.76%
REVENUE FORECAST
Revenue Forecast Chart ATXI
EBIT FORECAST
EBIT Forecast Chart ATXI
NET INCOME FORECAST
Net Income Chart ATXI